KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Other Non-Current Assets (2016 - 2026)

Ionis Pharmaceuticals (IONS) has disclosed Other Non-Current Assets for 18 consecutive years, with $135.6 million as the latest value for Q1 2026.

  • For Q1 2026, Other Non-Current Assets rose 2.83% year-over-year to $135.6 million; the TTM value through Mar 2026 reached $135.6 million, up 2.83%, while the annual FY2025 figure was $171.6 million, 34.83% up from the prior year.
  • Other Non-Current Assets hit $135.6 million in Q1 2026 for Ionis Pharmaceuticals, down from $171.6 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $171.6 million in Q4 2025 and bottomed at $58.9 million in Q2 2022.
  • Average Other Non-Current Assets over 5 years is $108.0 million, with a median of $106.0 million recorded in 2024.
  • Year-over-year, Other Non-Current Assets skyrocketed 75.12% in 2023 and then increased 2.83% in 2026.
  • Ionis Pharmaceuticals' Other Non-Current Assets stood at $75.3 million in 2022, then soared by 39.73% to $105.3 million in 2023, then rose by 20.89% to $127.3 million in 2024, then skyrocketed by 34.83% to $171.6 million in 2025, then decreased by 21.0% to $135.6 million in 2026.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $135.6 million, $171.6 million, and $166.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.